Reperio - About the company
Reperio is a series C company based in Portland (United States), founded in 2020 by Travis Rush and Matt Wallington. It operates as a Limited information available. Reperio has raised $52.7M in funding from Caduceus Capital Partners and Rogue Venture Partners. The company has 232 active competitors, including 55 funded and 13 that have exited. Its top competitors include companies like Function Health, Viome and 23andMe.
Company Details
- Website
- reperiohealth.com
- Email ID
- *****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com, *****@reperiohealth.com
- Registered Address
- 4784 SE 17TH AVE STE 120, PORTLAND, OR 97202
Key Metrics
Founded Year
2020
Location
Portland, United States
Stage
Series C
Total Funding
$52.7M in 8 rounds
Latest Funding Round
Investors
Ranked
15th among 232 active competitors
Employee Count
27 as on Sep 30, 2026
Legal entities associated with Reperio
Reperio is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
REPERIO HEALTH, INC. CIN: 163507396 , United States, Active | Jan 17, 2020 | - | - | - |
Sign up to download Reperio's company profile
Reperio's funding and investors
Reperio has raised a total funding of $52.7M over 8 rounds. Its first funding round was on Oct 15, 2020. Its latest funding round was a Series C round on May 21, 2025 for $*****. 1 investor participated in its latest round. Reperio has 5 institutional investors.
Here is the list of recent funding rounds of Reperio:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
May 21, 2025 | 2768535 | Series C | 7607267 | 2901626 | 6015304 | 3942100 |
May 23, 2024 | 1575124 | Series B | 1659318 | 8467171 | 2588474 | 6850915 |
Feb 09, 2024 | 1888918 | Series B | 2368434 | 1706541 | 1614196 |
View details of Reperio's funding rounds and investors
Reperio's founders and board of directors
Founder? Claim ProfileThe founders of Reperio are Travis Rush and Matt Wallington.
Here are the details of Reperio's key team members:
- Travis Rush: Co-Founder & CEO of Reperio and founder of 1 other company. They are also an angel investor in 1 startup and serve on the board of 1 company.Contact Info: 1 email address
- Matt Wallington: Co-Founder & CTO of Reperio and founder of 3 other companies, Cargo, GridVid and CPUsage. Contact Info: 1 email address
Reperio's Board of Directors
Reperio's board has 8 active members. Travis Rush, Matthew Wallington, TORY ADAMS, JUSTIN AUTREY, ELIZABETH CURTIS, Philip Hertik, ILDIKO CRIST and CHARLES JEWELL are independent board members.Here is the list of Reperio's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 6y 0m | |
dnfqtfi | Independent board member | - | Current | 5y 4m |
lzwhsfi | Independent board member | - | Current | 4y 2m |
rmmkvkh | Independent board member | - | Current | 7y 8m |
lks{bwq | Independent board member | - | Current | 9y 2m |
qbrrrkz | Independent board member | - | Current | 3y 1m |
cgfyemu | Independent board member | - | Current | 9y 3m |
j{y{cdi | Independent board member | - | Current | 7y 3m |
View details of Reperio's Founder profiles and Board Members
Reperio's employee count trend
Reperio has 27 employees as of Sep 26. Here is Reperio's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Reperio's Competitors and alternates
Top competitors of Reperio include Function Health, Viome and 23andMe. Here is the list of Top 10 competitors of Reperio, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Function Health 2022, Austin (United States), Series B | Provider of comprehensive lab testing and health monitoring membership services | $351M | 75/100 | |
2nd | Viome 2016, Bellevue (United States), Series D | Provider of a machine learning based bioinformatics solutions | $292M | 74/100 | |
3rd | 23andMe 2006, Sunnyvale (United States), Acquired | Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | $944M | 73/100 | |
4th | Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 73/100 | |
5th | Color 2013, Burlingame (United States), Series E | Provider of end-to-end Virtual clinic offering cancer-based solutions | $491M | 66/100 | |
6th | Ash 2019, New York City (United States), Series A | Provider of at-home diagnostics. | $47.5M | 63/100 | |
7th | Visby Medical 2010, San Jose (United States), Series F | Provider of at-home tests for sexually transmitted infections with telehealth | $386M | 60/100 | |
8th | Sequential Bio 2019, New York City (United States), Series A | Provider of in-vivio microbiome testing platform for skin care | $7.5M | 63/100 | |
9th | Legacy 2014, Cambridge (United States), Series B | Provider of at-home sperm testing and storage services | $47.7M | 63/100 | |
10th | LetsGetChecked 2013, Dublin (Ireland), Series D | Online platform to order at home diagnostic tests for all health conditions | $285M | 62/100 | |
15th | Reperio 2020, Portland (United States), Series C | Limited information available | $52.7M | 60/100 |
Looking for more details on Reperio's competitors? Click here to see the top ones
Reperio's Investments and acquisitions
Reperio has made no investments or acquisitions yet.
Reports related to Reperio
Here is the latest report on Reperio's sector:
News related to Reperio
Media has covered Reperio for a total of 2 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
Reperio Health Appoints Industry Veteran Brad Nations To Board of DirectorsBusiness Wire•Oct 07, 2026•Reperio
•
Reperio Health and Amazon One Medical Redefine the Front Door to Primary CareBusiness Wire•Jan 29, 2026•Reperio, Amazon
•
Reperio Health Deepens National Footprint, Adds Industry Vets to Drive At-Home Preventive Care AccessBusiness Wire•Oct 14, 2025•Reperio
•
•
Reperio Health Closes $14M Funding Round to Bring Their At-Home Preventive Care Solution to All 50 StatesThe Joplin Globe•May 21, 2025•Reperio
•
Reperio Health has filed a notice of an exempt offering of securities to raise $4,000,000.00 in New Equity Investment.intelligence360•Jul 18, 2024•Reperio
•
In-home health screening startup Reperio raises $14M, inks deal with UberGeekWire•Apr 19, 2024•Reperio, Uber, Caduceus Capital Partners, Rogue Venture Partners and 1 other
•
•
RxBenefits Partners with Springbuk in Innovative New Health Intelligence Marketplace for Employers and Benefits AdvisorsGlobeNewswire•Jan 16, 2024•RxBenefits, Springbuk, HealthJoy, Reperio
•
Reperio Health Enables Vanderbilt Health Employer Solutions to Add At-Home Screenings to its Growing PortfolioBusiness Wire•Jan 10, 2024•Reperio, Vanderbilt Health
Are you a Founder ?
FAQs about Reperio
Explore our recently published companies
- Washington Heritage Paintworks - Bethesda based, Unfunded company
- MB Media Inc - Unfunded company
- Washington Field Guide - Unfunded company
- Washington Fiber Forge - Unfunded company
- Washington DC Furnished Housing - Highlands Ranch based, Unfunded company
- Washington County Concrete - United States based, Unfunded company
